This study examined CD8+ cell distribution in hepatocellular carcinoma (HCC) and peritumoral liver tissue to investigate the overall survival (OS) and recurrence-free survival (RFS). It
EZH2 is the catalytic component of Polycomb Repressive Complex 2 (PRC2) and performs trimethylation of histone H3 at lysine 27 (H3K27me3) to silence chromatin. PRC2
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.
Masterclass Webinar: Intro to the HALO AI Toolbox Read More »
Indica Labs’ Image Management System Vendor Evaluation Template Our Vendor Evaluation Template was designed to provide you with the essential questions to ask when searching
Indica Labs’ Image Management System Vendor Evaluation Template Read More »
Albuquerque, NM and Seoul, South Korea – 25 April 2023 – Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform company focused on cancer biomarkers announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP® image management software platform and Lunit’s suite of AI pathology products. The combined solution is already in use at Guardant Health, a leading precision oncology company.
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor Evaluation Template will be provided to live attendees to assist in vendor evaluations, helping you more effectively identify a platform that meets your current needs and supports your plans for growth. In the second half of the webinar, we will present a live demonstration of the HALO AP® platform, including how to deploy image analysis and AI-based tools from Indica Labs and third parties for predictive or prognostic support.
Albuquerque, USA and Eindhoven, The Netherlands – April 17th, 2023 – Xyall and Indica Labs have entered into a global strategic partnership designed to bridge the gap between histology and molecular pathology. It unites Xyall’s unique automated tissue dissection solutions with Indica Labs’ AI-powered, diagnostic digital pathology platform.
See HALO® or HALO AI in action on up to three of your images with a free analysis.
Proof-of-Concept Image Analysis Read More »
4 May 2023 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 4 from 1 pm – 6 pm.
An interview with Jason Shaw, Software Engineer– Infrastructure, Indica Labs
An Interview with Jason Shaw, Software Engineer – Infrastructure, Indica Labs Read More »
